1. Home
  2. BRDG vs ALT Comparison

BRDG vs ALT Comparison

Compare BRDG & ALT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BRDG
  • ALT
  • Stock Information
  • Founded
  • BRDG 2009
  • ALT 1997
  • Country
  • BRDG United States
  • ALT United States
  • Employees
  • BRDG N/A
  • ALT N/A
  • Industry
  • BRDG Investment Managers
  • ALT Biotechnology: Pharmaceutical Preparations
  • Sector
  • BRDG Finance
  • ALT Health Care
  • Exchange
  • BRDG Nasdaq
  • ALT Nasdaq
  • Market Cap
  • BRDG 439.3M
  • ALT 457.0M
  • IPO Year
  • BRDG 2021
  • ALT N/A
  • Fundamental
  • Price
  • BRDG $10.64
  • ALT $6.90
  • Analyst Decision
  • BRDG Buy
  • ALT Buy
  • Analyst Count
  • BRDG 7
  • ALT 6
  • Target Price
  • BRDG $11.08
  • ALT $18.80
  • AVG Volume (30 Days)
  • BRDG 240.5K
  • ALT 1.8M
  • Earning Date
  • BRDG 11-06-2024
  • ALT 11-05-2024
  • Dividend Yield
  • BRDG 4.87%
  • ALT N/A
  • EPS Growth
  • BRDG N/A
  • ALT N/A
  • EPS
  • BRDG N/A
  • ALT N/A
  • Revenue
  • BRDG $368,472,000.00
  • ALT $409,000.00
  • Revenue This Year
  • BRDG $42.64
  • ALT N/A
  • Revenue Next Year
  • BRDG $33.61
  • ALT N/A
  • P/E Ratio
  • BRDG N/A
  • ALT N/A
  • Revenue Growth
  • BRDG 27.71
  • ALT N/A
  • 52 Week Low
  • BRDG $6.18
  • ALT $2.09
  • 52 Week High
  • BRDG $10.95
  • ALT $14.84
  • Technical
  • Relative Strength Index (RSI)
  • BRDG 68.63
  • ALT 55.14
  • Support Level
  • BRDG $9.93
  • ALT $5.92
  • Resistance Level
  • BRDG $10.76
  • ALT $7.24
  • Average True Range (ATR)
  • BRDG 0.32
  • ALT 0.35
  • MACD
  • BRDG 0.02
  • ALT 0.08
  • Stochastic Oscillator
  • BRDG 78.77
  • ALT 74.24

About BRDG Bridge Investment Group Holdings Inc.

Bridge Investment Group Holdings Inc is a vertically integrated investment manager, diversified across specialized asset classes. The company combines its nationwide operating platform with dedicated teams of investment professionals focused on various specialized and synergistic investment platforms, including real estate, credit, renewable energy, and secondaries strategies. Its broad range of products and vertically integrated structure allow it to capture new market opportunities and serve investors with various investment objectives. The company operates Its business in a single segment, alternative investment management, diversified across specialized and synergistic investment platforms.

About ALT Altimmune Inc.

Altimmune Inc is engaged in developing treatments for obesity and liver diseases. The Company's pipeline includes next-generation peptide therapeutics for obesity and non-alcoholic steatohepatitis (NASH) (for both, pemvidutide, formerly known as ALT-801), and for chronic hepatitis B (HepTcell). The Company is managed and operates as a single business focused on the research and development of treatments for various diseases and disorders, and vaccines.

Share on Social Networks: